Updates on Pharmaceutical Supply and Oil Market Earnings

This chapter covers the return of Eli Lilly's diabetes and obesity medications to the market, which is a positive development for consumers. It also analyzes recent earnings reports from Exxon Mobil and Chevron, emphasizing Exxon's record profits compared to Chevron's struggles and its exit from California.